Anaphylaxis

Food Allergy

Seasonal Allergy

Allergy

Biosimilars

Arrhythmia

Atherosclerotic Cardiovascular Disease

Dyslipidemia

Heart Failure

Hypertension

Stroke

Structural Heart Disease

Venous Thromboembolism

Cardiology

Acne

Atopic Dermatitis

Chronic Idiopathic Urticaria

Hidradenitis Suppurativa

Plaque Psoriasis

Rosacea

Vitiligo

Dermatology

Hormonal Disorders

Polycystic Ovary Syndrome

Thyroid Disorders

Type 1 Diabetes

Type 2 Diabetes

Endocrinology

FDA News

COVID-19

Influenza

Vaccination

Family Medicine

C Difficile Infection

Gastroesophageal Reflux Disease (GERD)

Inflammatory Bowel Disease

Irritable Bowel Syndrome

Peptic Ulcer

Ulcerative Colitis

Gastroenterology

Alzheimer Disease

Parkinson Disease

Geriatrics

Anemia

Sickle Cell

Hematology

Alpha-1 antitrypsin deficiency

Cholangitis

Hepatitis C

MASH / MASLD

Hepatology

Hospital Medicine

HIV/AIDS

Infectious Disease

Internal Medicine

Chronic Kidney Disease

IgA Nephropathy

Nephrology

Epilepsy

Migraine

Tardive Dyskinesia

Traumatic Brain Injury

Neurology

Obesity Management

Age-Related Macular Degeneration

Diabetic Macular Edema

Geographic Atrophy

Uveitis

Ophthalmology

Acute Pain

Chronic Pain

Multiple Sclerosis

Neuropathic Pain

Pain

Pediatrics

ADHD

Addiction

Bipolar Disorder

Major Depressive Disorder

PTSD

Schizophrenia

Psychiatry

Asthma

COPD

Lung Cancer

Pulmonary Fibrosis

Pulmonology

Amyloidosis

Huntington Disease

Lysosomal Storage Disorders

Vasculitis

RDR Alert®

Fibromyalgia

Gout

Lupus

Osteoarthritis

Osteoporosis

Psoriatic Arthritis

Rheumatoid Arthritis

Spondyloarthritis

Rheumatology

Insomnia

Obstructive Sleep Apnea

Sleep

Plastic surgery

Surgery

Women's Health

News

Media

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

CURE Connections®

Insights

Medcast Podcasts

Medcast Videos

News Network

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Digital Supplements

Interactive Tools

Live Events

Press Release

Publications

Advisory Board

Subscribe

Abigail Brooks is an assistant editor for 

She joined MJH Life Sciences in August 2023 shortly after graduating from Monmouth University where she earned her BA in Communication with a concentration in Public Relations/Journalism and later an MA in Interactive Digital Media. She enjoys traveling, running, and reading books. She can be reached at abrooks@mjhlifesciences.com.

Articles

Loomba reviews safety and efficacy data for the thyroid hormone receptor beta agonist from a phase 2a trial presented at AASLD The Liver Meeting 2024.

Rohit Loomba, MD: Promising Phase 2a HERALD Data for ALG-055009 in MASH

Ahmad Masri, MD, MS, is the director of the Hypertrophic Cardiomyopathy Center at Oregon Health and Science University. 

Ahmad Masri, MD, MS, discusses data from the FOREST-HCM trial examining effects of aficamten in patients with oHCM eligible for septal reduction therapy at baseline. 

Open-Label Study Finds Aficamten Could Help Most oHCM Patients Avoid Surgery

Tim Smith joined the MJH Life Sciences team as an assistant editor for HCPLive in August 2022. He graduated from UC Berkeley with a degree in political science, working in multimedia journalism as a staff writer prior to joining MJH. In his spare time, he enjoys reading, watching TV, listening to podcasts, and rock climbing. You can contact him at 

These retrospective, 52-week data highlight the efficacy and safety of bimekizumab for those with moderate-to-severe psoriasis.

Long-Term Bimekizumab Treatment Shown to be Effective for Patients with Psoriasis

Ahmad Masri, MD, MS, discusses a study from AHA 2024 detailing changing risk profiles and outcomes in trials among patients with ATTR-CM.

Recent Advances Have Improved Prognosis in ATTR-CM Patients, with Ahmad Masri, MD, MS

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

About Us

Advertise

Editorial

Contact Us

Do Not Sell My Information

Privacy

Terms & Conditions

HCPLive - Clinical news for connected physicians

Facebook

LinkedIn

Spotlight

The Respiratory Report

Biosimilars Spotlight

DME & nAMD On-Demand Presentation

Clinical

Arterial Disease

Diabetes

Geriatric Medicine

Video Series

Post Conference Perspectives

View

Real-World Evidence on the Efficacy and Durability of Novel Therapies for nAMD, DME, and RVO

Retinal Disease Management: Cases of Wet AMD and DME

Retina specialists come together to share key insights from multiple patient cases, highlighting how novel therapies like faricimab and aflibercept 8 mg have improved durability and patient outcomes in neovascular AMD, DME, and RVO.

nAMD and DME: Aflibercept 8mg and Faricimab Success Stories

Management of nAMD and DME with Faricimab

Treatment Extension with Faricimab: Case Examples

State of Sciences-Presentations

Retinal Disease Management: Cases of Wet AMD and DME

EP: 1.nAMD and DME: Aflibercept 8mg and Faricimab Success Stories

EP: 2.Retinal Disease Management: Cases of Wet AMD and DME

EP: 3.Management of nAMD and DME with Faricimab

EP: 4.Treatment Extension with Faricimab: Case Examples